Skip to main content

Management of transfusion dependant thalassemia.

Transfusion dependant thalassemias:

  • 80-85% of homozygous β° thalassemias
  • 25% of homozygous β+ thalassemias

Treatment:

1. Guidelines for Transfusion therapy:

  • RBC depleted of leukocytes
  • Matched for D,C,c,E,e & kell Ag
  • Cytomegalovirus safe units for stem cell transplantation candidates
  • Usual intervals 3-4wks
  • Hb goal 9.5-10.5g/dl
    • Monitor for
    • Transfusion ass infections
    • Transfusion ass reactions
    • Alloimmunization

2. Monitoring for iron overload:

Serum ferritin: screening technique
R2 MRI Quantitative liver Iron: best indicator usually started at 10yr.
Chelation therapy:
Chelation used in case of iron overload
General after 1 yr of transfusion
S. Ferritin > 1000ng/ml
Liver Iron >5000μg/g dry weight
Not <2yrs of age
Goals
  1. Prevent hemosiderosis induced tissue injury
  2. Avoid chelation toxicity.
Chelators

Deferoxamine

Deferasirox

Deferiprone

I.V / S.C

Oral

Oral 2nd line

8hr/d for 5-7days/wk

O.D

T.D.S

25mg/kg - 60mg/kg

20mg/kg/d -

40mg/kg/d

75mg/kg/d -

99mg/kg/d

Excellent safety

and efficacy

Adherence

Easily enter cardiac & other tissues

Skin reaction

Ototoxic

Retinal changes

Bone dysplasia

Truncal shortening

Kidney damage

G.I symptoms

Hepatic transaminitis

Transient Agranulocytosis

C.I when febrile


3. Hydroxyurea:

Used in β thalassemia intermedia
Dose: 10mg/kg - 20mg/kg
Mean increase in Hb is 1gm/dl
Reduced risk of
    • Leg ulcers
    • Pulmonary HTN
    • Extramedullary hematopoiesis
Risk of developing cytopenia

4. Hemopoietic stem cell transplantation:

In low risk HLA matched siblings
- survival rate is 90%
- event free survival is 80%
Gene therapy with lentiviral vectors for no donar pts 

5. Splenectomy:

Indications:
  • hypesplenism
  • falling steady state Hb
  • ↑ transfusions frequency
Adverse effects:
  • Infections risk
  • Venous thrombosis
  • Pulmonary HTN
  • Leg ulcers
  • Silent cerebral infarction
Prophylaxis:
  • Prophylactic penicillin
  • Immunization against capsulated bacteria

Preventive monitoring of Thalassemia pts:

1. Cardiac disease:

Major cause of death
Periodic electrocardiogram from 10yrs of age - risk of arrhythmias
Serial electrocardiogram to monitor
  • Cardiac function
  • Pulmonary artery pressure (Pulmonary HTN frequently occurs in non transfusion dependant pts - indication of BT)
After 8yrs chronic transfusions - cardiac hemosiderosis may occur
  • Require T2 MRI for diagnosis
  • Intense combination chelation therapy

2. Endocrine disease:

↓ endocrinal functions usually after 5yrs age/ 3yrs transfusion therapy due to
  • Hemosiderosis in pituitary and other glands causes
    • Hypothyroidism
    • G.H deficiency
    • Hypo parathyroidism
    • Diabetes mellitus
    • Osteoporosis
    • Adrenal insufficiency
  • Nutritional deficiencies
Measures:
Bi-annual: Height, weight, pubertal development
From 10yrs age: Bone scan
Vit D, Vit C, Zn supplementation

3. Psychological support:

  • Culturally sensitive anticipatory counseling
  • Early use of child life services
  • Early social service consultation for financial & social issues

Comments

Popular posts from this blog

Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines

Lab tests: Routine screening of family members of children with NCC is not recommended. If at all screening is performed, fecal testing of the family for ova/cyst can be done. The use of serological tests for diagnosis and clinical decision making in children with NCC is not recommended. Radiological tests: The MRI need not be done following CT in the following situations -  The CT conclusively demonstrates the presence of a scolex within the cyst  In the absence of demonstration of scolex – If a solitary cystic/ring-enhancing lesion has all other typical sizes, shape, and location characteristics of NCC Multiple lesions in different stages are present, including some cystic or ring enhancing or calcified MRI should be considered after CT in the following situations – Atypical imaging features (conglomerate lesions, subarachnoid or intraventricular lesions) along with the absence of scolex CT features create suspicion of intraventricular, subarachnoid, or intraspinal NCC Atypical clin

IAP Guidelines on junk food and fruit juices

 Target group: 1. Infants and adolescents aged between 6mo - 18yrs. 2. Children with normal growth and nutrition. 3. Not applicable to malnourished or ill children 4. Do not pertain to commercial formulations and therapeutic diets. THE JUNCS FOODS: J - JUNK Food: "foods (packed or non-packed, processed or non-processed) which contains little or limited presence of proteins, vitamins, phytochemicals, minerals and dietary fiber but are rich in fat (saturated fatty acids), salt and sugar and high in energy (calories) that are known to have negative impact on health if consumed regularly or in high amounts." U - Ultra Processed Foods "formulations of ingredients, mostly of exclusive industrial use that result from a series of industrial processes, including fractioning of whole foods into substances (sugars, oils and fats, proteins, starches and fiber), hydrolysis or hydrogenation, food assembly, coloring and flavouring." N - Nutritionally inappropriate foods C- Caffe